Dapagliflozin/Metformin Krka

Dapagliflozin/Metformin Krka combines two oral diabetes medications for blood sugar management. This fixed-dose combination is designed to support glycemic control in adults with type 2 diabetes.

Dapagliflozin/Metformin Krka is used to manage blood sugar levels in adults with type 2 diabetes. This combination therapy helps improve glycemic control by addressing insulin resistance and promoting glucose excretion. It is often prescribed when diet and exercise alone are not sufficient to manage blood sugar levels effectively.

Common effects of Dapagliflozin/Metformin Krka may include urinary tract infections, genital fungal infections, and gastrointestinal discomfort. Some individuals may experience increased urination or mild hypoglycemia, especially when combined with other diabetes medications.

Handle Dapagliflozin/Metformin Krka with care, especially if you have a history of kidney issues or are prone to dehydration. Regular monitoring of blood sugar levels is recommended. Consult a healthcare provider before use if you have any underlying health conditions.

Dapagliflozin/Metformin Krka may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol consumption should be moderated, as it can affect blood sugar levels and increase the risk of side effects.